Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.33
-0.92%
After-hours: Aug 15, 2025, 04:23 PM EDT

Vanda Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
203.47M 201.35M 198.77M 190.86M 182.02M 177.6M 192.64M 211.85M 238.35M 256.69M 254.38M 257.92M 262.7M 266.2M 268.68M 268.32M 258.53M 252.84M
Cost of Revenue
13.15M 13.15M 15.08M 15.95M 16.47M 15.48M 14.8M 17.57M 20.83M 23.39M 24.28M 24.28M 24.76M 25.26M 25.63M 25.8M 24.91M 24.19M
Gross Profit
190.32M 188.2M 183.69M 174.9M 165.56M 162.12M 177.84M 194.28M 217.52M 233.3M 230.1M 233.64M 237.94M 240.94M 243.05M 242.51M 233.62M 228.65M
Operating Income
-104.33M -75.97M -40.66M -37.48M -32.47M -25.19M -13.95M -229K 9.67M 16M 6.33M 8.34M 15.25M 24.16M 42.16M 43.98M 40.9M 37.7M
Interest Income
n/a n/a n/a n/a 5.88M 11.33M 14.86M 17.84M 13.52M 8.06M 4.54M 1.55M n/a n/a n/a n/a n/a n/a
Pretax Income
-85M -55.63M -22.92M -18.09M -11.96M -3.85M 6.34M 17.61M 23.19M 24.39M 11.3M 10.3M 15.56M 24.37M 42.36M 44.68M 42.36M 40.84M
Net Income
-66.94M -44.25M -18.9M -16.39M -10.93M -4.89M 2.51M 11.77M 14.9M 15.96M 6.28M 6.49M 10.99M 18.07M 33.15M 34.26M 32.44M 31.5M
Selling & General & Admin
191.56M 166.41M 146.41M 130.75M 117.94M 106.86M 112.88M 122.05M 127.14M 131.74M 136.49M 137.15M 139.75M 135.1M 124.05M 126.17M 127.72M 133.29M
Research & Development
94.32M 88.99M 74.43M 78.93M 78.75M 78.74M 76.82M 70.94M 79.19M 84.04M 85.77M 86.65M 81.44M 80.2M 75.36M 70.88M 63.53M 56.18M
Other Expenses
8.78M 8.78M 3.5M 7.18M 5.43M 5.43M 5.81M 758K 1.14M 1.52M 1.52M 1.11M 635K 491K 199K 698K 1.45M 1.22M
Operating Expenses
292.9M 262.43M 222.6M 212.38M 198.03M 187.31M 191.8M 194.51M 207.85M 217.29M 223.77M 225.3M 222.69M 216.79M 200.89M 198.53M 192.72M 190.94M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a 500K 500K 500K 500K 2.6M 2.6M 2.6M 2.6M 6.7M 6.7M 6.7M 6.7M 12.6M 12.6M 12.6M
Cost & Expenses
307.8M 277.32M 239.43M 228.33M 214.49M 202.79M 206.59M 212.08M 228.68M 240.69M 248.05M 249.58M 247.45M 242.05M 226.52M 224.34M 217.63M 215.13M
Income Tax Expense
-18.06M -11.38M -4.02M -1.7M -1.03M 1.04M 3.83M 5.84M 8.29M 8.44M 5.03M 3.81M 4.57M 6.3M 9.21M 10.41M 9.92M 9.34M
Shares Outstanding (Basic)
58.99M 58.53M 58.31M 58.26M 58.22M 57.76M 57.53M 57.52M 57.45M 57.01M 56.65M 56.57M 56.51M 56.11M 55.79M 55.67M 55.58M 55.15M
Shares Outstanding (Diluted)
58.99M 58.53M 58.31M 58.26M 58.22M 57.76M 57.53M 57.6M 57.54M 57.4M 57.19M 56.97M 56.82M 56.11M 57.23M 57.04M 56.9M 56.51M
EPS (Basic)
-1.14 -0.75 -0.33 -0.28 -0.19 -0.08 0.04 0.21 0.26 0.28 0.11 0.12 0.21 0.33 0.60 0.62 0.59 0.58
EPS (Diluted)
-1.14 -0.75 -0.33 -0.28 -0.19 -0.08 0.04 0.21 0.26 0.28 0.11 0.11 0.20 0.32 0.58 0.60 0.57 0.56
EBITDA
-81.32M -56.63M -32.53M -30.16M -26.54M -20.63M -10.94M 2.29M 12.29M 18.7M 9.06M 11.11M 18.05M 26.98M 45.01M 46.83M 43.76M 40.56M
EBIT
-88.26M -63.52M -40.66M -37.48M -32.47M -25.19M -10.43M 3.29M 13.2M 19.86M 6.66M 8.66M 15.48M 24.06M 42.07M 44.36M 41.38M 38.18M
Depreciation & Amortization
6.94M 6.89M 8.13M 7.32M 5.93M 4.56M 3.01M 2.52M 2.61M 2.7M 2.73M 2.78M 2.81M 2.83M 2.84M 2.85M 2.51M 2.17M